Therapeutic Asset Ratings
3,272 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nogitecan
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
National Cancer Institute (NCI)
P2
CCC
(53)
Nogitecan
Fallopian Tube Mucinous Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nogitecan
Ovarian Mucinous Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Obeticholic Acid
Attenuated Familial Adenomatous Polyposis
National Cancer Institute (NCI)
P2
CCC
(53)
Obeticholic Acid
Duodenal Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Obeticholic Acid
Classic Familial Adenomatous Polyposis
National Cancer Institute (NCI)
P2
CCC
(53)
Obinutuzumab
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)
P2
CCC
(53)
Obinutuzumab
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
National Cancer Institute (NCI)
P2
CCC
(53)
Obinutuzumab
High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Prostate Neuroendocrine Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Endometrial Mixed Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Endometrial Serous Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Endometrial Undifferentiated Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Fallopian Tube Endometrioid Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Fallopian Tube Mucinous Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Histiocytic Sarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Juvenile Xanthogranuloma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Ovarian Endometrial Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Pancreatic Acinar Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Pancreatic Adenosquamous Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Squamous Cell Carcinoma Of Pancreas
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Ewing Sarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Olaparib
Ovarian Mucinous Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Showing 1826 to 1850 of 3,272 assets
Previous
Page 74 of 131
Next